Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Anti-androgens might help reduce COVID-19 severity in men.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Testosterone may influence COVID-19 severity and outcomes.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Antiandrogens don't help with COVID-19 and aren't recommended.

Gut bacteria overgrowth may cause some Post-Finasteride Syndrome symptoms.

Gut bacteria overgrowth may cause some Post-Finasteride Syndrome symptoms.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.